16 results found
Searchresult 1 - 10 of 16. You filter by “Studies” and “Healthcare”.
-
Evaluation of ACM’s Guidelines on the collective procurement of prescription drugs
ACM’s Guidelines on the collective procurement of prescription drugs have helped in the negotiations with drug manufacturers.
-
Sector inquiry into TNF alpha inhibitors
ACM conducted a sector inquiry into TNF alpha inhibitors. The expiration of patents has led to lower prices. To guarantee their affordability in the future, competitors must be able to gain a solid position on the Dutch market.
-
Product market definition in hospital care in the Netherlands
ACM has commissioned a research into the definition of product markets in the hospital care and what proportion of that care can be defined as complex care.
-
ACM Working Paper: Reconciling competition and IP law: the case of patented pharmaceuticals and dominance abuse
Even if medicines have a patent, competition law can deal with excessive prices or abuse of a dominant position.
-
Explanatory notes: Intensified attention for anticompetitive risks of hospital mergers
ACM has, based on recent studies, intensified its attention for anticompetitive risks of hospital mergers.